247 related articles for article (PubMed ID: 10915092)
21. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
22. Prospects for vaccine protection against HIV-1 infection and AIDS.
Letvin NL; Barouch DH; Montefiori DC
Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
[TBL] [Abstract][Full Text] [Related]
23. Vaccines directed against HIV: preventive and therapeutic strategies.
Kahn JO; Birx DL
AIDS Clin Rev; 1993-1994; ():213-38. PubMed ID: 8217900
[TBL] [Abstract][Full Text] [Related]
24. Lessons for AIDS vaccine development from non-AIDS vaccines.
Clements-Mann ML
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S197-203. PubMed ID: 9814944
[TBL] [Abstract][Full Text] [Related]
25. The role of nonhuman primates in the development of an AIDS vaccine.
Nathanson N; Hirsch VM; Mathieson BJ
AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
[TBL] [Abstract][Full Text] [Related]
26. Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types.
Gilbert PB; Self SG; Ashby MA
Biometrics; 1998 Sep; 54(3):799-814. PubMed ID: 9750238
[TBL] [Abstract][Full Text] [Related]
27. Encouraging vaccine results from primate models of HIV type 1 infection.
Schultz A
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S261-3. PubMed ID: 9814953
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in AIDS vaccine research and development.
Johnston MI; Noe JS; Killen JY
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S317-23. PubMed ID: 7865330
[TBL] [Abstract][Full Text] [Related]
29. The role of mucosal immunity in development of an acquired immunodeficiency syndrome (AIDS) vaccine: workshop summary.
Muul LM; Glass MJ; Wescott SL; Burkhardt AL; Koff WC; Strober WG
Reg Immunol; 1989; 2(3):188-92. PubMed ID: 2701579
[TBL] [Abstract][Full Text] [Related]
30. HIV vaccine development and evaluation: realistic expectations.
Heyward WL; MacQueen KM; Goldenthal KL
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S205-10. PubMed ID: 9814945
[TBL] [Abstract][Full Text] [Related]
31. Strategies for AIDS vaccines.
Stott EJ; Schild GC
J Antimicrob Chemother; 1996 May; 37 Suppl B():185-98. PubMed ID: 8818840
[TBL] [Abstract][Full Text] [Related]
32. Towards an AIDS vaccine: the role of nonhuman primates.
Nathanson N; Mathieson BJ
J Med Primatol; 1999; 28(4-5):146-53. PubMed ID: 10593479
[TBL] [Abstract][Full Text] [Related]
33. [Current aspects of HIV infection].
Gürtler LG
Beitr Infusionsther; 1991; 28():1-6. PubMed ID: 1725606
[TBL] [Abstract][Full Text] [Related]
34. Elite controllers as a model of functional cure.
Autran B; Descours B; Avettand-Fenoel V; Rouzioux C
Curr Opin HIV AIDS; 2011 May; 6(3):181-7. PubMed ID: 21460722
[TBL] [Abstract][Full Text] [Related]
35. Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines.
Koff WC; Russell ND; Walport M; Feinberg MB; Shiver JW; Karim SA; Walker BD; McGlynn MG; Nweneka CV; Nabel GJ
Vaccine; 2013 Apr; 31 Suppl 2():B204-8. PubMed ID: 23598483
[TBL] [Abstract][Full Text] [Related]
36. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?
Sekaly RP
J Exp Med; 2008 Jan; 205(1):7-12. PubMed ID: 18195078
[TBL] [Abstract][Full Text] [Related]
37. What is required of an HIV vaccine?
Bangham CR; Phillips RE
Lancet; 1997 Nov; 350(9091):1617-21. PubMed ID: 9393353
[TBL] [Abstract][Full Text] [Related]
38. Challenges in the development of an HIV-1 vaccine.
Barouch DH
Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
[TBL] [Abstract][Full Text] [Related]
39. Prospects for an AIDS vaccine: three big questions, no easy answers.
Garber DA; Silvestri G; Feinberg MB
Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
[TBL] [Abstract][Full Text] [Related]
40. Genetically identical primate modelling systems for HIV vaccines.
Kent SJ; Lewis IM
Reprod Fertil Dev; 1998; 10(7-8):651-7. PubMed ID: 10612472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
